Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Free Report) CEO James W. Green acquired 20,000 shares of the business’s stock in a transaction dated Thursday, June 6th. The stock was purchased at an average price of $3.07 per share, with a total value of $61,400.00. Following the acquisition, the chief executive officer now owns 3,101,091 shares […]
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
16.05.2024 - HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) - Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark .
StockNews.com Lowers Harvard Bioscience (NASDAQ:HBIO) to Hold kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.